Literature DB >> 8453039

Transforming growth factor-beta 1 is in plaques in Alzheimer and Down pathologies.

E A van der Wal1, F Gómez-Pinilla, C W Cotman.   

Abstract

Transforming growth factor-beta (TGF-beta) is a major modulator of the extracellular matrix and cell growth, and shows affinity for and interaction with several substances present in plaques in Alzheimer's disease (AD). In order to examine a possible role of TGF-beta in plaque biogenesis, we studied its distribution in the limbic system of AD and Down's syndrome (DS) brains. Select plaques displayed TGF-beta 1 immunoreactivity in AD and DS. TGF-beta 1 plaques were mainly located in the molecular layer of the dentate gyrus in AD, while in DS TGF-beta 1 plaques were preferentially located in the entorhinal cortex. In AD, TGF-beta 1 immunoreactivity was also shown in neurofibrillary tangles. The presence of TGF-beta 1 in plaques suggests that TGF-beta 1 may play a role in the cascade of events leading to plaque formation.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8453039     DOI: 10.1097/00001756-199301000-00018

Source DB:  PubMed          Journal:  Neuroreport        ISSN: 0959-4965            Impact factor:   1.837


  56 in total

1.  The chondroitin sulfate proteoglycans neurocan and phosphacan are expressed by reactive astrocytes in the chronic CNS glial scar.

Authors:  R J McKeon; M J Jurynec; C R Buck
Journal:  J Neurosci       Date:  1999-12-15       Impact factor: 6.167

2.  Chronic overproduction of transforming growth factor-beta1 by astrocytes promotes Alzheimer's disease-like microvascular degeneration in transgenic mice.

Authors:  T Wyss-Coray; C Lin; D A Sanan; L Mucke; E Masliah
Journal:  Am J Pathol       Date:  2000-01       Impact factor: 4.307

3.  Bioluminescence imaging of Smad signaling in living mice shows correlation with excitotoxic neurodegeneration.

Authors:  Jian Luo; Amy H Lin; Eliezer Masliah; Tony Wyss-Coray
Journal:  Proc Natl Acad Sci U S A       Date:  2006-11-16       Impact factor: 11.205

4.  Effects of transforming growth factor-beta (isoforms 1-3) on amyloid-beta deposition, inflammation, and cell targeting in organotypic hippocampal slice cultures.

Authors:  M E Harris-White; T Chu; Z Balverde; J J Sigel; K C Flanders; S A Frautschy
Journal:  J Neurosci       Date:  1998-12-15       Impact factor: 6.167

Review 5.  Neuroinflammation in Alzheimer's disease: mechanisms, pathologic consequences, and potential for therapeutic manipulation.

Authors:  Kenneth Hensley
Journal:  J Alzheimers Dis       Date:  2010       Impact factor: 4.472

6.  Brain Atrophy, Anti-Smooth Muscle Antibody and Cognitive Impairment: An Association Study.

Authors:  Paroni Giulia; Lauriola Michele; Fontana Andrea; D'Onofrio Grazia; Ciccone Filomena; Paris Francesco; Cascavilla Leandro; Urbano Maria; Gravina Carolina; Copetti Massimiliano; Greco Antonio
Journal:  Aging Dis       Date:  2015-11-24       Impact factor: 6.745

7.  TGF-β1 Regulation of P-JNK and L-Type Calcium Channel Cav1.2 in Cortical Neurons.

Authors:  Zhenning Liu; Jiangtao Sheng; Guoyi Peng; Jinhua Yang; Weiqiang Chen; Kangsheng Li
Journal:  J Mol Neurosci       Date:  2018-02-08       Impact factor: 3.444

Review 8.  Role of the immune system in the pathogenesis, prevention and treatment of Alzheimer's disease.

Authors:  Imrich Blasko; Beatrix Grubeck-Loebenstein
Journal:  Drugs Aging       Date:  2003       Impact factor: 3.923

9.  Sp1 and Smad transcription factors co-operate to mediate TGF-beta-dependent activation of amyloid-beta precursor protein gene transcription.

Authors:  Fabian Docagne; Cecilia Gabriel; Nathalie Lebeurrier; Sylvain Lesné; Yannick Hommet; Laurent Plawinski; Eric T Mackenzie; Denis Vivien
Journal:  Biochem J       Date:  2004-10-15       Impact factor: 3.857

10.  Microarray expression analysis reveals genetic pathways implicated in C621 synphilin-1-mediated toxicity.

Authors:  M Bonin; F P Marx; S Kautzmann; O Riess; R Krüger
Journal:  J Neural Transm (Vienna)       Date:  2008-02-22       Impact factor: 3.575

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.